Tables
- Table 1
The most important published studies assessing the efficacy of the e-nose for lung cancer
First author [ref.] Year Lung cancer patients included/total study participants Type of nose Result Philips [36] 2008 95/180 Gas chromatography and mass spectroscopy Sensitivity: 74%; specificity: 71% Bajtarevic [35] 2009 220/661 Gas chromatography and mass spectrometry Sensitivity: 71; specificity: 100% Dragonieri [39] 2009 10/30 Cyranose Cross-validation value of 90% correct; sensitivity and specificity not reported D’Amico [40] 2010 28/148 Gas chromatography and mass spectroscopy Sensitivity: 85%; specificity: 100% Gasparri [41] 2016 70/146 Gas sensor array composed of quartz microbalances Sensitivity: 81%; specificity: 91% Rocco [12] 2016 23/100 Pneumopipe Sensitivity: 86%; specificity: 95% De Vries [15] 2018 35/604 Spironose Sensitivity 80%; specificity 90% Huang [28] 2018 56/244 Cyranose Multiple models
Support vector machine
Sensitivity: 83%; specificity: 86%Tirzïte [26] 2018 252/475 Cyranose Two different models for smokers (sensitivity: 96%; specificity: 92%) and nonsmokers (sensitivity: 96%; specificity: 91%) Kort [27] 2018 144/290 Aeonose Multiple models used in the same population
Sensitivity: 94%; specificity: 33% (for the NSCLC model)Van de Goor [42] 2018 52/144 Aeonose Sensitivity: 83%; specificity: 84%